- Home
- ALUR vs BIAF Comparison
ALUR vs BIAF Comparison
Compare ALUR & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- BIAF
- Stock Information
- Founded
- ALUR 2009
- BIAF 2014
- Country
- ALUR United States
- BIAF United States
- Employees
- ALUR N/A
- BIAF N/A
- Industry
- ALUR
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ALUR
- BIAF Health Care
- Exchange
- ALUR Nasdaq
- BIAF Nasdaq
- Market Cap
- ALUR 15.4M
- BIAF 13.0M
- IPO Year
- ALUR N/A
- BIAF 2022
- Fundamental
- Price
- ALUR $1.56
- BIAF $2.02
- Analyst Decision
- ALUR Buy
- BIAF Hold
- Analyst Count
- ALUR 2
- BIAF 1
- Target Price
- ALUR $9.25
- BIAF N/A
- AVG Volume (30 Days)
- ALUR 40.6K
- BIAF 1.3M
- Earning Date
- ALUR 11-13-2025
- BIAF 11-14-2025
- Dividend Yield
- ALUR N/A
- BIAF N/A
- EPS Growth
- ALUR N/A
- BIAF N/A
- EPS
- ALUR N/A
- BIAF N/A
- Revenue
- ALUR $19,917,000.00
- BIAF $7,681,059.00
- Revenue This Year
- ALUR N/A
- BIAF N/A
- Revenue Next Year
- ALUR N/A
- BIAF $20.04
- P/E Ratio
- ALUR N/A
- BIAF N/A
- Revenue Growth
- ALUR N/A
- BIAF 4.99
- 52 Week Low
- ALUR $1.52
- BIAF $1.91
- 52 Week High
- ALUR $19.49
- BIAF $46.53
- Technical
- Relative Strength Index (RSI)
- ALUR 22.34
- BIAF 41.30
- Support Level
- ALUR $1.61
- BIAF $2.01
- Resistance Level
- ALUR $2.03
- BIAF $2.33
- Average True Range (ATR)
- ALUR 0.10
- BIAF 0.20
- MACD
- ALUR -0.03
- BIAF -0.07
- Stochastic Oscillator
- ALUR 7.84
- BIAF 10.48
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.